- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
Safety Principles
PhRMA members are committed to the development of life-saving and life-enhancing medicines. PhRMA has adopted the following core principles when it comes to medicine safety and safety monitoring:
Principle 1:
Patient safety is our highest priority. We need a strong and effective FDA with the resources and personnel necessary to ensure the safety of the U.S. drug supply and continued access to innovative medicines.
Principle 2:
Patient welfare should be at the center of any effort to enhance drug safety and ensure that benefits and risks are balanced.
Principle 3:
Drug safety and effectiveness monitoring must be comprehensive and continuous. PhRMA supports efforts that seek to continually improve these activities.
Principle 4:
Patients and health care providers must have accurate, timely, and useful information on which to base their decisions.



